Dissemin is shutting down on January 1st, 2025

Published in

Springer Nature [academic journals on nature.com], Cancer Gene Therapy, 2(12), p. 133-140, 2004

DOI: 10.1038/sj.cgt.7700758

Links

Tools

Export citation

Search in Google Scholar

Bifidobacterium longum as an oral delivery system of endostatin for gene therapy on solid liver cancer.

Journal article published in 1970 by Geng-Feng Fu, Xi Li, Ya-Yi Hou, Wen-Hua Liu, Gen-Xing Xu, Yan-Rong Fan, Fu Gf ORCID
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

To overcome difficulties that hampered widespread application of a specific delivery system in cancer gene therapy and to inhibit the growth of solid liver cancer, we utilized a strain of Bifidobacterium longum as a delivery system to transport an endostatin gene that can inhibit growth of tumor. The B. longum strain with the endostatin gene (B. longum-En) was taken orally by tumor-bearing nude mice through drencher preparation. The results showed that B. longum-En could strongly inhibit the growth of solid liver tumor in nude mice and prolong the survival time of tumor-bearing nude mice. Furthermore, tumor growth was inhibited more efficiently when the B. longum-En treatment included selenium. Enriching the B. longum-En treatment with selenium improves the activity of NK and T cells and stimulates the activity of IL-2 and TNF-alpha in BALB/c mice. These results suggest that B. longum may be a highly specific and efficient vector for transporting anticancer genes in cancer gene therapy.